Immune checkpoint inhibitors in GBM
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Neurology (clinical),Neurology,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s11060-021-03859-8.pdf
Reference59 articles.
1. Bagchi S, Yuan R, Engleman EG (2021) Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance. Annu Rev Pathol 16:223–249. https://doi.org/10.1146/annurev-pathol-042020-042741
2. Khasraw M, Reardon DA, Weller M, Sampson JH (2020) PD-1 inhibitors: do they have a future in the treatment of glioblastoma? Clin Cancer Res 26:5287–5296. https://doi.org/10.1158/1078-0432.Ccr-20-1135
3. Wen PY, Weller M, Lee EQ, Alexander BM, Barnholtz-Sloan JS, Barthel FP, Batchelor TT, Bindra RS, Chang SM, Chiocca EA, Cloughesy TF, DeGroot JF, Galanis E, Gilbert MR, Hegi ME, Horbinski C, Huang RY, Lassman AB, Le Rhun E, Lim M, Mehta MP, Mellinghoff IK, Minniti G, Nathanson D, Platten M, Preusser M, Roth P, Sanson M, Schiff D, Short SC, Taphoorn MJB, Tonn JC, Tsang J, Verhaak RGW, von Deimling A, Wick W, Zadeh G, Reardon DA, Aldape KD, van den Bent MJ (2020) Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro-Oncology 22:1073–1113. https://doi.org/10.1093/neuonc/noaa106
4. Sampson JH, Gunn MD, Fecci PE, Ashley DM (2020) Brain immunology and immunotherapy in brain tumours. Nat Rev Cancer 20:12–25. https://doi.org/10.1038/s41568-019-0224-7
5. Dunn GP, Okada H (2015) Principles of immunology and its nuances in the central nervous system. Neuro-Oncology 17:vii3–vii8. https://doi.org/10.1093/neuonc/nov175
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Deciphering glycosylation-driven prognostic insights and therapeutic prospects in glioblastoma through a comprehensive regulatory model;Frontiers in Oncology;2024-05-22
2. Discovery of Novel Small-Molecule-Based Potential PD-L1/EGFR Dual Inhibitors with High Druggability for Glioblastoma Immunotherapy;Journal of Medicinal Chemistry;2024-05-13
3. UBA2 as a Prognostic Biomarker and Potential Therapeutic Target in Glioma;Frontiers in Bioscience-Landmark;2024-04-09
4. Novel Clinical Trials and Approaches in the Management of Glioblastoma;Current Oncology Reports;2024-03-28
5. Therapeutic Strategies for Gliomas Associated With Cancer Predisposition Syndromes;JCO Precision Oncology;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3